GENE ONLINE|News &
Opinion
Blog

2021-09-15| Asia-Pacific

Japan’s Nippon Foundation Injects $210M into Osaka University’s 10-Year Infectious Diseases Research Plan

by Tyler Chen
Share To

The Nippon Foundation announced September 14 that it will inject $210 million (23 billion yen) to support the Infectious Disease Control Project, managed by Osaka University, for 10 years. The university had established a research center for infectious diseases back in April 2021.

 

Japan’s COVID Cases Subsided But Extended State of Emergency Persists

Japan’s daily COVID-19 cases reached their peak in late August but subsided in the past two weeks. However, the Japanese government is still extending the state of emergency in 19 prefectures to September 30, including Tokyo, Hokkaido, Osaka, Aichi, and Fukuoka.

According to the WHO, Japan has fully vaccinated 60 million people, reaching a vaccination rate of 48%.

 

3 Goals to Achieve in the 10-Year Plan

The pandemic disrupted Japan’s medical system and economic growth. To stop Japan from taking a hit in the next pandemic, the collaboration aims to develop forward-looking strategies to tackle critical issues the country has failed to address.

There are 3 goals in the 10-year plan. The first is to promote basic research of infectious diseases. The center will conduct research to understand the mechanism of the human immune system, antigens, and microbes related to the diseases, and develop treatments against them. 

Osaka University has made its name in the field of basic medicine, immunology, microbial diseases. The capacity of the research center can allow up to 90 researchers.

Next, the research will delve into social psychology and behavioral economics. The partnership is expected to deliver results that can decrease the impact of pandemics and maximize the range of allowed economic and social activities. Moreover, the center will provide insights to the government and accelerate decision-making when infectious diseases hit.

Last but not least, Osaka University will train over 10,000 medical talents to combat infectious diseases so that the medical system won’t collapse from a lack of manpower.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top